Viewing Study NCT00688493


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT00688493
Status: COMPLETED
Last Update Posted: 2012-03-21
First Post: 2008-05-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Effects of Single Oral Dose Dapagliflozin QT Study
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module